Ben Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ben Huang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Yongxin Sun
Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
7 shared publications - Chunsheng Wang
Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
3 shared publications - Chunsheng Wang
Department of Cardiac Surgery and Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China
3 shared publications - Libin Yang
Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2 shared publications - Mieradilijiang Abudupataer
Department of Cardiac Surgery and Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2 shared publications - Quanlin Yang
Department of Cardiac Surgery, Zhongshan Hospital Xiamen Branch, Fudan University, Xiamen 361006, China
2 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by MDPI AG in Micromachines
- Vol. 17 (11) , 1329
Computer-Controlled Balloon Manometry Coupled with Inverse Finite Element Analysis for Assessing Chronic Radiation-Induced Rectal Injury in Rats
Quantitative assessment of chronic radiation-induced rectal injury (RRI) requires methods that relate tissue remodeling to mechanical function. We integrated computer-controlled balloon manometry, inverse finite element analysis, and paired whole-wall histopathology in a preclinical exploratory workflow. Male Sprague–Dawley rats received 0, 12, 20, or 28 Gy pelvic irradiation and were assessed at 3–4 months. Of 32 enrolled rats, 29 contributed tissue assessments and 26 yielded paired mechanical and histopathological data. Balloon-corrected pressure–volume curves were analyzed with a three-parameter Yeoh model using a common axisymmetric geometry. The recorded coefficient c10 and the post hoc index cmax = max(c10, c20) were associated with injury scores (Spearman ρ = 0.5955 and 0.6675, respectively). Differences from correlations for selected pressure measures were not formally tested. Higher cmax also accompanied edema, fibrosis, and vascular stenosis in exploratory comparisons. Model-archive inspection identified a nearly incompressible formulation and an inconsistency between the radius used in the fitted volume expression and the geometric radius. The outputs have not been recomputed; the coefficients remain provisional descriptors of the archived workflow. The contribution is the integration of controlled loading with a histological reference. Selective testability, unvalidated loading safety, the volume-definition discrepancy, and unestablished parameter identifiability prevent interpretation as validated tissue stiffness or clinical performance.
- 16 November 2026
- Published by MDPI AG in Micromachines
- Vol. 17 (11) , 1329
Open AccessComputer-Controlled Balloon Manometry Coupled with Inverse Finite Element Analysis for Assessing Chronic Radiation-Induced Rectal Injury in Rats
Quantitative assessment of chronic radiation-induced rectal injury (RRI) requires methods that relate tissue remodeling to mechanical function. We integrated computer-controlled balloon manometry, inverse finite element analysis, and paired whole-wall histopathology in a preclinical exploratory workflow. Male Sprague–Dawley rats received 0, 12, 20, or 28 Gy pelvic irradiation and were assessed at 3–4 months. Of 32 enrolled rats, 29 contributed tissue assessments and 26 yielded paired mechanical and histopathological data. Balloon-corrected pressure–volume curves were analyzed with a three-parameter Yeoh model using a common axisymmetric geometry. The recorded coefficient c10 and the post hoc index cmax = max(c10, c20) were associated with injury scores (Spearman ρ = 0.5955 and 0.6675, respectively). Differences from correlations for selected pressure measures were not formally tested. Higher cmax also accompanied edema, fibrosis, and vascular stenosis in exploratory comparisons. Model-archive inspection identified a nearly incompressible formulation and an inconsistency between the radius used in the fitted volume expression and the geometric radius. The outputs have not been recomputed; the coefficients remain provisional descriptors of the archived workflow. The contribution is the integration of controlled loading with a histological reference. Selective testability, unvalidated loading safety, the volume-definition discrepancy, and unestablished parameter identifiability prevent interpretation as validated tissue stiffness or clinical performance.
- Open Access
- 30 September 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2218
Integrated Analysis of Serotonin-Related Biomarkers in Thoracic Aortic Aneurysm Based on Machine Learning and Single-Cell Sequencing Data
Background: Serotonin, as an important neurotransmitter and signaling molecule, can affect thoracic aortic aneurysm (TAA) by regulating vascular cell proliferation, angiogenesis, and immune status. This research aimed to conduct a comprehensive analysis to pinpoint serotonin-related biomarkers in TAA and to elucidate their potential molecular mechanisms. Methods: Biomarkers were selected and validated through differential expression analysis, weighted gene co-expression network analysis (WGCNA), machine learning algorithms, and expression verification. Moreover, the constructed nomogram, enrichment analysis, immune infiltration analysis, and compound prediction validated the regulatory roles of the biomarkers in TAA. The single-cell dataset was analyzed to determine key cells and perform pseudo-time analysis. Simulated knockout of biomarkers was performed to determine their underlying functions and related pathways. Finally, reverse transcription quantitative PCR (RT-qPCR) was employed to confirm the expression levels of the biomarkers. Results: Overall, two biomarkers (CD300A and CLU) were determined to be associated with serotonin in TAA. The nomogram showed good performance in predicting TAA risk. These biomarkers were significantly enriched in the hematopoietic cell lineage and natural killer (NK) cell mediated cytotoxicity. Biomarker expression was significantly correlated with the infiltration proportions of M2 macrophages and neutrophils. The biomarkers were stably bound to tetrachlorodibenzodioxin and bisphenol A. Moreover, pseudo-time analysis demonstrated a notable correlation between biomarker expression and the differentiation status of monocytes/macrophages/dendritic cells (MonoMac/DC). Genes perturbed by knockout were enriched in the pyrimidine metabolism and RIG-I-like receptor signaling pathway. Finally, RT-qPCR validated that CLU was downregulated and CD300A was upregulated in the TAA group. Conclusions: Biomarkers (CD300A and CLU) associated with serotonin in TAA were identified, with their expression trends validated by RT-qPCR. This work provides novel bioinformatic insights, and direct functional experiments are required to support future therapeutic development for TAA.
- 30 September 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2218
Open AccessIntegrated Analysis of Serotonin-Related Biomarkers in Thoracic Aortic Aneurysm Based on Machine Learning and Single-Cell Sequencing Data
Background: Serotonin, as an important neurotransmitter and signaling molecule, can affect thoracic aortic aneurysm (TAA) by regulating vascular cell proliferation, angiogenesis, and immune status. This research aimed to conduct a comprehensive analysis to pinpoint serotonin-related biomarkers in TAA and to elucidate their potential molecular mechanisms. Methods: Biomarkers were selected and validated through differential expression analysis, weighted gene co-expression network analysis (WGCNA), machine learning algorithms, and expression verification. Moreover, the constructed nomogram, enrichment analysis, immune infiltration analysis, and compound prediction validated the regulatory roles of the biomarkers in TAA. The single-cell dataset was analyzed to determine key cells and perform pseudo-time analysis. Simulated knockout of biomarkers was performed to determine their underlying functions and related pathways. Finally, reverse transcription quantitative PCR (RT-qPCR) was employed to confirm the expression levels of the biomarkers. Results: Overall, two biomarkers (CD300A and CLU) were determined to be associated with serotonin in TAA. The nomogram showed good performance in predicting TAA risk. These biomarkers were significantly enriched in the hematopoietic cell lineage and natural killer (NK) cell mediated cytotoxicity. Biomarker expression was significantly correlated with the infiltration proportions of M2 macrophages and neutrophils. The biomarkers were stably bound to tetrachlorodibenzodioxin and bisphenol A. Moreover, pseudo-time analysis demonstrated a notable correlation between biomarker expression and the differentiation status of monocytes/macrophages/dendritic cells (MonoMac/DC). Genes perturbed by knockout were enriched in the pyrimidine metabolism and RIG-I-like receptor signaling pathway. Finally, RT-qPCR validated that CLU was downregulated and CD300A was upregulated in the TAA group. Conclusions: Biomarkers (CD300A and CLU) associated with serotonin in TAA were identified, with their expression trends validated by RT-qPCR. This work provides novel bioinformatic insights, and direct functional experiments are required to support future therapeutic development for TAA.
- Open Access
- 29 July 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (8) , 356
Indobufen Versus Aspirin After CABG for Unstable Angina in Patients Aged 70 Years and Older
Background: Postoperative antiplatelet selection after coronary artery bypass grafting (CABG) in adults aged ≥70 years requires balancing ischemic protection against bleeding risk. Methods: We conducted a single-center retrospective cohort study of adults aged ≥70 years who underwent isolated CABG for unstable angina between 2017 and 2021. The exposure was the initial discharge antiplatelet pathway: aspirin 100 mg once daily or indobufen 100 mg twice daily as the cyclooxygenase-inhibitor component, combined with a P2Y12 inhibitor during the first postoperative year and followed by the same cyclooxygenase inhibitor during the second year. Propensity scores were estimated using multivariable logistic regression with 16 prespecified baseline covariates, and stabilized inverse probability of treatment weighting (IPTW) was applied. The primary analyses used IPTW-weighted Cox models. Results: Among 336 screened patients, 79 were included in the final analytic cohort (aspirin-based pathway, n = 49; indobufen-based pathway, n = 30). After weighting, measured covariate balance improved, although residual imbalance remained for prior myocardial infarction and prior percutaneous coronary intervention. At 24 months, no statistically significant association was observed between pathway and MACCE (HR 0.858, 95% CI 0.257–2.866; p = 0.803), BARC grade ≥2 bleeding (HR 0.359, 95% CI 0.093–1.385; p = 0.137), or NACE (HR 0.526, 95% CI 0.204–1.360; p = 0.185). Graft surveillance was evaluable in 77/79 patients at 1 year and 71/79 at 2 years and was analyzed descriptively. Conclusions: In this real-world cohort of older patients undergoing CABG for unstable angina, an initial indobufen-based discharge pathway was not statistically significantly associated with 24-month MACCE, BARC grade ≥2 bleeding, or NACE compared with an aspirin-based pathway after stabilized IPTW. These findings add exploratory CABG-specific data on indobufen in older patients and should be confirmed in larger prospective studies.
- 29 July 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (8) , 356
Open AccessIndobufen Versus Aspirin After CABG for Unstable Angina in Patients Aged 70 Years and Older
Background: Postoperative antiplatelet selection after coronary artery bypass grafting (CABG) in adults aged ≥70 years requires balancing ischemic protection against bleeding risk. Methods: We conducted a single-center retrospective cohort study of adults aged ≥70 years who underwent isolated CABG for unstable angina between 2017 and 2021. The exposure was the initial discharge antiplatelet pathway: aspirin 100 mg once daily or indobufen 100 mg twice daily as the cyclooxygenase-inhibitor component, combined with a P2Y12 inhibitor during the first postoperative year and followed by the same cyclooxygenase inhibitor during the second year. Propensity scores were estimated using multivariable logistic regression with 16 prespecified baseline covariates, and stabilized inverse probability of treatment weighting (IPTW) was applied. The primary analyses used IPTW-weighted Cox models. Results: Among 336 screened patients, 79 were included in the final analytic cohort (aspirin-based pathway, n = 49; indobufen-based pathway, n = 30). After weighting, measured covariate balance improved, although residual imbalance remained for prior myocardial infarction and prior percutaneous coronary intervention. At 24 months, no statistically significant association was observed between pathway and MACCE (HR 0.858, 95% CI 0.257–2.866; p = 0.803), BARC grade ≥2 bleeding (HR 0.359, 95% CI 0.093–1.385; p = 0.137), or NACE (HR 0.526, 95% CI 0.204–1.360; p = 0.185). Graft surveillance was evaluable in 77/79 patients at 1 year and 71/79 at 2 years and was analyzed descriptively. Conclusions: In this real-world cohort of older patients undergoing CABG for unstable angina, an initial indobufen-based discharge pathway was not statistically significantly associated with 24-month MACCE, BARC grade ≥2 bleeding, or NACE compared with an aspirin-based pathway after stabilized IPTW. These findings add exploratory CABG-specific data on indobufen in older patients and should be confirmed in larger prospective studies.
- Open Access
- 2 May 2026
- Published by MDPI AG in Micromachines
- Vol. 17 (5) , 568
Development of a Multi-Channel and Multilayered PDMS Microfluidic Platform for Real-Time Visualization and Multi-Condition Parallel Testing of Mechanically Stimulated Cells
We developed a multi-channel and multilayered polydimethylsiloxane (PDMS) microfluidic platform that integrates cyclic mechanical stimulation, independent reagent delivery, and real-time optical observation within a single device. The platform employs a four-layer architecture comprising a pneumatic valve control layer, an observation channel for cell culture and imaging (24 mm × 4 mm), a medium perfusion layer with independent inlet ports, and a vacuum actuation layer that deforms a 200 μm PDMS membrane under −20 kPa cyclic pressure at 1 Hz. Cyclic membrane strain of 10% was calibrated using fluorescent bead tracking and image analysis. Finite element analysis based on nonlinear Föppl–von Kármán plate theory confirmed that the central cell culture region (60% of membrane area) exhibits a mean von Mises strain of 14.2% with a uniformity of 81.3% (CV = 18.7%), validating relatively uniform mechanical stimulation across the culture surface. As a proof-of-concept, human aortic smooth muscle cells (CRL-1999) cultured under cyclic strain showed significant upregulation of HIF-1 expression (2.5-fold, ) and pronounced F-actin stress fiber alignment visualized by fluorescence microscopy, confirming the platform’s capability for mechanotransduction studies and real-time cellular observation. The multi-channel architecture enables multi-condition parallel testing by simultaneously introducing different reagent concentrations through independent inlet ports while maintaining identical mechanical parameters across all channels, providing a versatile tool for systematic investigation of cellular responses under controlled biomechanical conditions.- 2 May 2026
- Published by MDPI AG in Micromachines
- Vol. 17 (5) , 568
Open AccessDevelopment of a Multi-Channel and Multilayered PDMS Microfluidic Platform for Real-Time Visualization and Multi-Condition Parallel Testing of Mechanically Stimulated Cells
We developed a multi-channel and multilayered polydimethylsiloxane (PDMS) microfluidic platform that integrates cyclic mechanical stimulation, independent reagent delivery, and real-time optical observation within a single device. The platform employs a four-layer architecture comprising a pneumatic valve control layer, an observation channel for cell culture and imaging (24 mm × 4 mm), a medium perfusion layer with independent inlet ports, and a vacuum actuation layer that deforms a 200 μm PDMS membrane under −20 kPa cyclic pressure at 1 Hz. Cyclic membrane strain of 10% was calibrated using fluorescent bead tracking and image analysis. Finite element analysis based on nonlinear Föppl–von Kármán plate theory confirmed that the central cell culture region (60% of membrane area) exhibits a mean von Mises strain of 14.2% with a uniformity of 81.3% (CV = 18.7%), validating relatively uniform mechanical stimulation across the culture surface. As a proof-of-concept, human aortic smooth muscle cells (CRL-1999) cultured under cyclic strain showed significant upregulation of HIF-1 expression (2.5-fold, ) and pronounced F-actin stress fiber alignment visualized by fluorescence microscopy, confirming the platform’s capability for mechanotransduction studies and real-time cellular observation. The multi-channel architecture enables multi-condition parallel testing by simultaneously introducing different reagent concentrations through independent inlet ports while maintaining identical mechanical parameters across all channels, providing a versatile tool for systematic investigation of cellular responses under controlled biomechanical conditions. - Open Access
- 18 March 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (3)
ZNF460 Promotes GSDME-Driven Pyroptosis via PKM2 Transcriptional Activation in Aortic Dissection
Background: Aortic dissection (AD) is a cardiovascular emergency with high mortality; however, the underlying molecular pathophysiology of AD remains incompletely understood. Pyroptosis, a proinflammatory form of programmed cell death, contributes to vascular injury; nonetheless, the upstream transcriptional regulation of pyroptosis in AD is similarly poorly defined. Methods: Differentially expressed genes were identified in aortic tissues from AD patients (Gene Expression Omnibus (GEO) datasets) using bioinformatics analyses, with a focus on cell death-related candidates. In vivo AD mouse models and in vitro vascular smooth muscle cell (VSMC) systems were employed to investigate the roles of these genes in AD. Potential transcription factors for pyruvate kinase M2 (PKM2) were predicted using the Just Another Simple Array Retrieval/Simple API for Repository (JASPAR) and University of California, Santa Cruz (UCSC) databases, and validated by luciferase reporter and chromatin immunoprecipitation assays. Gain- and loss-of-function approaches were used to dissect the zinc finger protein 460 (ZNF460)–PKM2–gasdermin E (GSDME) axis and the associated impact on pyroptosis and AD progression. Results: PKM2 expression was markedly elevated in AD tissues. PKM2 silencing suppressed GSDME cleavage, attenuated VSMC pyroptosis, and mitigated experimental AD, whereas PKM2 overexpression aggravated these outcomes. GSDME upregulation rescued pyroptosis in PKM2-depleted cells. Mechanistically, the transcription factor ZNF460 directly bound to the PKM2 promoter, enhancing PKM2 transcription and activating downstream GSDME-mediated pyroptosis. ZNF460 knockdown reduced pyroptotic cell death and preserved aortic wall integrity in vivo. Conclusions: This study identifies ZNF460 as a novel upstream regulator of PKM2 that drives GSDME-dependent pyroptosis, thereby exacerbating AD progression. Targeting the ZNF460–PKM2–GSDME axis may represent a promising therapeutic strategy for preventing pyroptosis-driven vascular damage in AD.
- 18 March 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (3)
Open AccessZNF460 Promotes GSDME-Driven Pyroptosis via PKM2 Transcriptional Activation in Aortic Dissection
Background: Aortic dissection (AD) is a cardiovascular emergency with high mortality; however, the underlying molecular pathophysiology of AD remains incompletely understood. Pyroptosis, a proinflammatory form of programmed cell death, contributes to vascular injury; nonetheless, the upstream transcriptional regulation of pyroptosis in AD is similarly poorly defined. Methods: Differentially expressed genes were identified in aortic tissues from AD patients (Gene Expression Omnibus (GEO) datasets) using bioinformatics analyses, with a focus on cell death-related candidates. In vivo AD mouse models and in vitro vascular smooth muscle cell (VSMC) systems were employed to investigate the roles of these genes in AD. Potential transcription factors for pyruvate kinase M2 (PKM2) were predicted using the Just Another Simple Array Retrieval/Simple API for Repository (JASPAR) and University of California, Santa Cruz (UCSC) databases, and validated by luciferase reporter and chromatin immunoprecipitation assays. Gain- and loss-of-function approaches were used to dissect the zinc finger protein 460 (ZNF460)–PKM2–gasdermin E (GSDME) axis and the associated impact on pyroptosis and AD progression. Results: PKM2 expression was markedly elevated in AD tissues. PKM2 silencing suppressed GSDME cleavage, attenuated VSMC pyroptosis, and mitigated experimental AD, whereas PKM2 overexpression aggravated these outcomes. GSDME upregulation rescued pyroptosis in PKM2-depleted cells. Mechanistically, the transcription factor ZNF460 directly bound to the PKM2 promoter, enhancing PKM2 transcription and activating downstream GSDME-mediated pyroptosis. ZNF460 knockdown reduced pyroptotic cell death and preserved aortic wall integrity in vivo. Conclusions: This study identifies ZNF460 as a novel upstream regulator of PKM2 that drives GSDME-dependent pyroptosis, thereby exacerbating AD progression. Targeting the ZNF460–PKM2–GSDME axis may represent a promising therapeutic strategy for preventing pyroptosis-driven vascular damage in AD.
- Open Access
- 1 March 2026
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 21, 1-11
Indobufen versus Aspirin After CABG in Septuagenarians: A Propensity Score–Matched Cohort Study
To compare the safety and efficacy of indobufen-based versus aspirin-based sequential antiplatelet therapy in septuagenarians undergoing coronary artery bypass grafting (CABG). Patients aged 70–79 years who underwent CABG between 2020 and 2022 received either indobufen- or aspirin-based dual antiplatelet therapy (DAPT) (with clopidogrel) for 12 months, followed by monotherapy with their respective baseline agent (indobufen or aspirin) for an additional year. Propensity score matching (1:2, caliper 0.25 SD) balanced the baseline characteristics. The primary outcomes were 2-year major adverse cardiac and cerebrovascular events (MACCE) and Bleeding Academic Research Consortium (BARC) types 2, 3, or 5 bleeding. Among 296 patients (indobufen, 46; aspirin, 250), 104 (indobufen, 36; aspirin, 68) were well matched. Before matching, indobufen showed similar 2-year MACCE risk to aspirin (6.5% vs 6.8%; subdistribution hazard ratio [sHR] 0.96, 95% CI 0.28–3.28; p = 0.95) and lower BARC type 2, 3, or 5 bleeding (2.2% vs 6.8%; sHR 0.32, 95% CI 0.04–2.38; p = 0.23). After matching, results remained consistent (MACCE 8.3% vs 10.3%; sHR 0.81, 95% CI 0.21–3.10; p = 0.76; bleeding 2.8% vs 11.8%; sHR 0.24, 95% CI 0.03–1.87; p = 0.14). Indobufen reduced clinically relevant bleeding by 9.0% (number needed to treat [NNT] ≈ 11) without compromising ischemic outcomes. Indobufen-based sequential therapy provided ischemic protection similar to that of aspirin, while showing a favorable bleeding profile in septuagenarians undergoing CABG. For individuals with a high bleeding risk or aspirin intolerance, indobufen may represent a practical alternative. Larger prospective studies focusing on geriatric outcomes are warranted.
- 1 March 2026
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 21, 1-11
Open AccessIndobufen versus Aspirin After CABG in Septuagenarians: A Propensity Score–Matched Cohort Study
To compare the safety and efficacy of indobufen-based versus aspirin-based sequential antiplatelet therapy in septuagenarians undergoing coronary artery bypass grafting (CABG). Patients aged 70–79 years who underwent CABG between 2020 and 2022 received either indobufen- or aspirin-based dual antiplatelet therapy (DAPT) (with clopidogrel) for 12 months, followed by monotherapy with their respective baseline agent (indobufen or aspirin) for an additional year. Propensity score matching (1:2, caliper 0.25 SD) balanced the baseline characteristics. The primary outcomes were 2-year major adverse cardiac and cerebrovascular events (MACCE) and Bleeding Academic Research Consortium (BARC) types 2, 3, or 5 bleeding. Among 296 patients (indobufen, 46; aspirin, 250), 104 (indobufen, 36; aspirin, 68) were well matched. Before matching, indobufen showed similar 2-year MACCE risk to aspirin (6.5% vs 6.8%; subdistribution hazard ratio [sHR] 0.96, 95% CI 0.28–3.28; p = 0.95) and lower BARC type 2, 3, or 5 bleeding (2.2% vs 6.8%; sHR 0.32, 95% CI 0.04–2.38; p = 0.23). After matching, results remained consistent (MACCE 8.3% vs 10.3%; sHR 0.81, 95% CI 0.21–3.10; p = 0.76; bleeding 2.8% vs 11.8%; sHR 0.24, 95% CI 0.03–1.87; p = 0.14). Indobufen reduced clinically relevant bleeding by 9.0% (number needed to treat [NNT] ≈ 11) without compromising ischemic outcomes. Indobufen-based sequential therapy provided ischemic protection similar to that of aspirin, while showing a favorable bleeding profile in septuagenarians undergoing CABG. For individuals with a high bleeding risk or aspirin intolerance, indobufen may represent a practical alternative. Larger prospective studies focusing on geriatric outcomes are warranted.
- Open Access
- 12 December 2025
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 25, 101383
Global burden of ischemic heart disease attributable to temperature extremes in adults aged 40 years and older: Trends, inequalities, and projections (1990–2050)
- 12 December 2025
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 25, 101383
Open AccessGlobal burden of ischemic heart disease attributable to temperature extremes in adults aged 40 years and older: Trends, inequalities, and projections (1990–2050)
- Open Access
- 2 October 2023
- Published by Wiley in Advanced Biology
- Vol. 8 (1) , e2300292
HIF‐1α Contributes to Hypoxia‐induced VSMC Proliferation and Migration by Regulating Autophagy in Type A Aortic Dissection
Type A aortic dissection (AD) is a catastrophic cardiovascular disease. Hypoxia‐inducible factor‐1α (HIF‐1α) and autophagy are reported to be upregulated in the AD specimens. However, the interaction between HIF‐1α and autophagy in the pathogenesis of AD remains to be explored. HIF‐1α and LC3 levels are evaluated in 10 AD and 10 normal aortic specimens. MDC staining, autophagic vacuoles, and autophagic flux are detected in human aortic smooth muscle cells (HASMCs) under hypoxia treatment. CCK‐8, transwell, and wound healing assay are used to identify proliferation and migration under hypoxia treatment. Furthermore, 3‐MA is used to inhibit autophagy in hypoxia‐treated HASMCs. This study reveals that AD tissues highly express HIF‐1α and the LC3. Autophagy is induced under hypoxia in a time‐dependent manner, and autophagy is positively related to HIF‐1α in HASMCs. Moreover, the proliferation and migration of HASMCs are enhanced by hypoxia, whereas the knockdown of HIF‐1α attenuates this effect. Additionally, inhibiting autophagy with 3‐MA ameliorates hypoxia‐induced proliferation and migration of HASMCs. In summary, the above results indicate that HIF‐1α facilitates HASMC proliferation and migration by upregulating autophagy in a hypoxic microenvironment. Thus, inhibition of autophagy may be a novel therapeutic target for the prevention and treatment of AD.
- 2 October 2023
- Published by Wiley in Advanced Biology
- Vol. 8 (1) , e2300292
Open AccessHIF‐1α Contributes to Hypoxia‐induced VSMC Proliferation and Migration by Regulating Autophagy in Type A Aortic Dissection
Type A aortic dissection (AD) is a catastrophic cardiovascular disease. Hypoxia‐inducible factor‐1α (HIF‐1α) and autophagy are reported to be upregulated in the AD specimens. However, the interaction between HIF‐1α and autophagy in the pathogenesis of AD remains to be explored. HIF‐1α and LC3 levels are evaluated in 10 AD and 10 normal aortic specimens. MDC staining, autophagic vacuoles, and autophagic flux are detected in human aortic smooth muscle cells (HASMCs) under hypoxia treatment. CCK‐8, transwell, and wound healing assay are used to identify proliferation and migration under hypoxia treatment. Furthermore, 3‐MA is used to inhibit autophagy in hypoxia‐treated HASMCs. This study reveals that AD tissues highly express HIF‐1α and the LC3. Autophagy is induced under hypoxia in a time‐dependent manner, and autophagy is positively related to HIF‐1α in HASMCs. Moreover, the proliferation and migration of HASMCs are enhanced by hypoxia, whereas the knockdown of HIF‐1α attenuates this effect. Additionally, inhibiting autophagy with 3‐MA ameliorates hypoxia‐induced proliferation and migration of HASMCs. In summary, the above results indicate that HIF‐1α facilitates HASMC proliferation and migration by upregulating autophagy in a hypoxic microenvironment. Thus, inhibition of autophagy may be a novel therapeutic target for the prevention and treatment of AD.
- 11 March 2022
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 62 (2)
Outcomes of thoracic endovascular aortic repair for penetrating aortic ulcers involving the left subclavian artery with the Castor single-branched stent graft
Objects: To acquire adequate proximal landing zones for penetrating aortic ulcers in the proximal descending aorta or aortic arch, the left subclavian artery (LSA) is usually covered during thoracic endovascular aortic repair. The Castor single-branched stent graft is used to treat aortic disease involving LSA. Our goal was to evaluate the efficiency and safety of the Castor device in treating penetrating aortic ulcers (PAUs) involving the LSA. METHODS: Between January 2019 and December 2020, we enrolled 25 patients with PAUs requiring LSA revascularization using Castor devices during thoracic endovascular aortic repair (TEVAR). Outcomes including surgical results, 30-day and follow-up deaths and morbidity and aortic computed tomography angiography data were analyzed. RESULTS: In total, 24 patients (96.0%) underwent successful surgical procedures: 1 patient (4.0%) had a type I endoleak and 1 patient (4.0%) had a stroke. Stent migration occurred in 1 patient (4.0%) and paraplegia in 1 patient (4.0%). Two stents were deployed in 2 patients (8.0%). After a mean follow-up period of 15.7 months, 2 cases of branch occlusions and 1 death related to myocardial infarction were noted. Aortic computed tomography angiography demonstrated that the diameters and depths were reduced significantly whereas complete thrombosis of the lumens of the PAUs occurred in all cases during the 12-months follow-up period. CONCLUSIONS: These preliminary results justify the efficiency and safety of the Castor single branched stent graft in the treatment of PAUs requiring LSA revascularization.
- 11 March 2022
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 62 (2)
Outcomes of thoracic endovascular aortic repair for penetrating aortic ulcers involving the left subclavian artery with the Castor single-branched stent graft
Objects: To acquire adequate proximal landing zones for penetrating aortic ulcers in the proximal descending aorta or aortic arch, the left subclavian artery (LSA) is usually covered during thoracic endovascular aortic repair. The Castor single-branched stent graft is used to treat aortic disease involving LSA. Our goal was to evaluate the efficiency and safety of the Castor device in treating penetrating aortic ulcers (PAUs) involving the LSA. METHODS: Between January 2019 and December 2020, we enrolled 25 patients with PAUs requiring LSA revascularization using Castor devices during thoracic endovascular aortic repair (TEVAR). Outcomes including surgical results, 30-day and follow-up deaths and morbidity and aortic computed tomography angiography data were analyzed. RESULTS: In total, 24 patients (96.0%) underwent successful surgical procedures: 1 patient (4.0%) had a type I endoleak and 1 patient (4.0%) had a stroke. Stent migration occurred in 1 patient (4.0%) and paraplegia in 1 patient (4.0%). Two stents were deployed in 2 patients (8.0%). After a mean follow-up period of 15.7 months, 2 cases of branch occlusions and 1 death related to myocardial infarction were noted. Aortic computed tomography angiography demonstrated that the diameters and depths were reduced significantly whereas complete thrombosis of the lumens of the PAUs occurred in all cases during the 12-months follow-up period. CONCLUSIONS: These preliminary results justify the efficiency and safety of the Castor single branched stent graft in the treatment of PAUs requiring LSA revascularization.
- Open Access
- 12 August 2021
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 16 (1) , 1-8
MicroRNAs involve in bicuspid aortic aneurysm: pathogenesis and biomarkers
The incidence of bicuspid aortic valves (BAV) is high in the whole population, BAV-related thoracic aortic aneurysm (TAA) is accompanied by many adverse vascular events. So far, there are two key points in dealing with BAV-related TAA. First is fully understanding on its pathogenesis. Second is optimizing surgical intervention time. This review aims to illustrate the potential role of miRNAs in both aspects, that is, how miRNAs are involved in the occurrence and progression of BAV-related TAA, and the feasibilities of miRNAs as biomarkers.
- 12 August 2021
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 16 (1) , 1-8
Open AccessMicroRNAs involve in bicuspid aortic aneurysm: pathogenesis and biomarkers
The incidence of bicuspid aortic valves (BAV) is high in the whole population, BAV-related thoracic aortic aneurysm (TAA) is accompanied by many adverse vascular events. So far, there are two key points in dealing with BAV-related TAA. First is fully understanding on its pathogenesis. Second is optimizing surgical intervention time. This review aims to illustrate the potential role of miRNAs in both aspects, that is, how miRNAs are involved in the occurrence and progression of BAV-related TAA, and the feasibilities of miRNAs as biomarkers.